| 期刊全稱 | Biotechnology in India II | | 影響因子2023 | Tarun K. Ghose,Purnendu Ghosh,S. Suryanarayan | | 視頻video | http://file.papertrans.cn/189/188753/188753.mp4 | | 發(fā)行地址 | This review series covers trends in modern biotechnology.All aspects of this interdisciplinary technology, where knowledge, methods and expertise are required from chemistry, biochemistry, microbiolog | | 學科分類 | Advances in Biochemical Engineering/Biotechnology | | 圖書封面 |  | | 影響因子 | The biotechnology business in India with an increase from USD 500 million in 1997 and reaching an estimated USD 1 billion next year health related prod ucts accounting for 60%, agro and veterinary products together 15%, and con tract R&D, reagents, devices and supplies adding up to the remaining 25% of which the diagnostics share was about 10% of the total surely presented an encouraging picture even five years ago. While volumes have increased, the pat tern has not. According to a report, prepared by McKinsey & Co, India‘s Phar maceutical industry including domestic and export sales and contract services totals nearly USD 5 billion. Furthermore, the company optimistically projects the growth to a factor of five fold only if both the industry and the government are able to put in place achievable solutions that must take care of the formida ble obstacles preventing further growth. If this assessment is correct, then the established transformation made by IT growth should also provide the confi dence required by the high expectations for biotechnology which have arisen in the country in recent years. Some contributors to this are overenthusiastic these are bureaucrats, some retired | | Pindex | Book 2003 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-9 05:51
發(fā)表于 2025-3-21 16:59:23
